TCM
PLSE icon

Tygh Capital Management’s Pulse Biosciences PLSE Stock Holding History

Tygh Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125,266
Closed -$2.97M – 94
2021
Q1 		$2.97M Buy
+125,266
New +$3.74M 0.42% 80

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Tygh Capital Management's PLSE Position: Q2 2021 in Review

Tygh Capital Management sold out of Pulse Biosciences (PLSE) in Q2 2021, closing a stake of 125,266 shares — an estimated $2.97M sold.

Tygh Capital Management first reported a position in PLSE in Q1 2021 and held it in 1 quarter. The position peaked at $2.97M in Q1 2021. 54 funds tracked by Wall St. Rank hold PLSE as of Q2 2021.

  • Tygh Capital Management reported no remaining Pulse Biosciences position as of Q2 2021 after selling out during the quarter.
  • Tygh Capital Management sold 125,266 Pulse Biosciences shares in Q2 2021, an estimated $2.97M.
  • Tygh Capital Management first reported a position in Pulse Biosciences in Q1 2021 and held it in 1 quarter.
  • Tygh Capital Management's Pulse Biosciences position peaked at $2.97M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2021.

Based on Tygh Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.